Physician profile
Rocco Morabito
NPI 1366649642
$6,263.64
in general payments reported to CMS, 2019-2025
34 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,700 · 2020: $409 · 2021: $104 · 2022: $716 · 2023: $990 · 2024: $592 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,266 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,266.23 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,844.36 | 2019-2020 | |
| Astellas Pharma US INC | $893.69 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Ethicon US, LLC | $657.79 | 2019-2025 | Vistaseal, Stratafix, Harmonic |
| Intuitive Surgical, INC. | $445.48 | 2019-2025 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $242.44 | 2023 | Gemtesa |
| Axonics, INC. | $227.03 | 2021-2024 | Axonics |
| Laborie Medical Technologies Corp. | $185.39 | 2023 | |
| Conmed Corporation | $169.58 | 2022-2023 | Airseal |
| Pfizer INC. | $146.95 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $131.46 | 2022-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $121.90 | 2022-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $121.80 | 2020-2023 | Xiaflex |
| Procept Biorobotics Corporation | $120.27 | 2019-2025 | Aquabeam System |
| Ambu INC. | $104.48 | 2023-2024 | |
| Endo USA, INC. | $97.59 | 2024-2025 | Xiaflex |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $91.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.62 | 2019-2025 | |
| Janssen Biotech, INC. | $80.59 | 2019-2024 | Erleada |
| Boston Scientific Corporation | $69.60 | 2019-2024 | Ams 700 |
| Abbvie INC. | $66.00 | 2019-2025 | |
| Olympus America INC. | $64.31 | 2025 | Itind System |
| Kowa Pharmaceuticals America, INC. | $45.07 | 2022 | |
| Teleflex LLC | $33.41 | 2024-2025 | Urolift, Barrigel |
| Allergan, INC. | $33.24 | 2019 | |
| Urovant Sciences INC | $31.95 | 2022 | |
| Rochester Medical Corporation | $25.49 | 2022 | |
| Bard Access Systems, INC. | $24.93 | 2019 | |
| Agiliti Surgical, INC. | $22.40 | 2023 | Cryocare Cs, Sonablate |
| Astrazeneca Pharmaceuticals LP | $20.78 | 2025 | Imfinzi |
| Alexion Pharmaceuticals, INC. | $20.34 | 2023 | Ultomiris |
| Tolmar Pharmaceuticals, INC. | $15.89 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.07 | 2024 | Adstiladrin |
| Merck Sharp & Dohme LLC | $12.33 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rocco Morabito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.